Genky DrugStores plans 200m yen restricted stock plan
Genky DrugStores plans to introduce a restricted stock compensation system for directors, requiring shareholder approval at its September 2025 annual meeting.
The proposal seeks approval for up to 200 million yen in restricted stock remuneration annually, separate from existing director compensation limits. The system will be capped at 100,000 shares per year, with share prices based on Tokyo Stock Exchange closing prices.
Directors will face transfer restrictions preventing them from selling, pledging or disposing of shares during specified periods.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Genky Drugstores publishes news
Free account required • Unsubscribe anytime